BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27570547)

  • 1. Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent.
    Abou-Elkacem L; Wilson KE; Johnson SM; Chowdhury SM; Bachawal S; Hackel BJ; Tian L; Willmann JK
    Theranostics; 2016; 6(11):1740-52. PubMed ID: 27570547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound molecular imaging as a non-invasive companion diagnostic for netrin-1 interference therapy in breast cancer.
    Wischhusen J; Wilson KE; Delcros JG; Molina-Peña R; Gibert B; Jiang S; Ngo J; Goldschneider D; Mehlen P; Willmann JK; Padilla F
    Theranostics; 2018; 8(18):5126-5142. PubMed ID: 30429890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
    Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
    Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.
    Wang H; Kaneko OF; Tian L; Hristov D; Willmann JK
    Invest Radiol; 2015 May; 50(5):322-9. PubMed ID: 25575176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Evaluation of Clinically Translatable Targeted Microbubbles Using a Microfluidic Device for In Vivo Ultrasound Molecular Imaging.
    Bam R; Natarajan A; Tabesh F; Paulmurugan R; Dahl JJ
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging.
    Deshpande N; Ren Y; Foygel K; Rosenberg J; Willmann JK
    Radiology; 2011 Mar; 258(3):804-11. PubMed ID: 21339349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
    Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
    Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Affibody-Based Ultrasound Molecular Imaging of Vascular B7-H3 for Breast Cancer Detection.
    Bam R; Lown PS; Stern LA; Sharma K; Wilson KE; Bean GR; Lutz AM; Paulmurugan R; Hackel BJ; Dahl J; Abou-Elkacem L
    Clin Cancer Res; 2020 May; 26(9):2140-2150. PubMed ID: 31924738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.
    Anderson CR; Hu X; Zhang H; Tlaxca J; Declèves AE; Houghtaling R; Sharma K; Lawrence M; Ferrara KW; Rychak JJ
    Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
    Willmann JK; Lutz AM; Paulmurugan R; Patel MR; Chu P; Rosenberg J; Gambhir SS
    Radiology; 2008 Sep; 248(3):936-44. PubMed ID: 18710985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model.
    Bachawal SV; Jensen KC; Lutz AM; Gambhir SS; Tranquart F; Tian L; Willmann JK
    Cancer Res; 2013 Mar; 73(6):1689-98. PubMed ID: 23328585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection.
    Pysz MA; Machtaler SB; Seeley ES; Lee JJ; Brentnall TA; Rosenberg J; Tranquart F; Willmann JK
    Radiology; 2015 Mar; 274(3):790-9. PubMed ID: 25322341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent.
    Turco S; Tardy I; Frinking P; Wijkstra H; Mischi M
    Phys Med Biol; 2017 Mar; 62(6):2449-2464. PubMed ID: 28240217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model.
    Lee DJ; Lyshchik A; Huamani J; Hallahan DE; Fleischer AC
    J Ultrasound Med; 2008 Jun; 27(6):855-66. PubMed ID: 18499845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and Imaging Investigation of Dual-targeted C
    Du J; Li XY; Hu H; Xu L; Yang SP; Li FH
    Sci Rep; 2018 Mar; 8(1):3887. PubMed ID: 29497045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See?
    Wang S; Herbst EB; Mauldin FW; Diakova GB; Klibanov AL; Hossack JA
    Invest Radiol; 2016 Dec; 51(12):758-766. PubMed ID: 27654582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the Clinical Development and Validation of a Thy1-Targeted Ultrasound Contrast Agent for the Early Detection of Pancreatic Ductal Adenocarcinoma.
    Bam R; Daryaei I; Abou-Elkacem L; Vilches-Moure JG; Meuillet EJ; Lutz A; Marinelli ER; Unger EC; Gambhir SS; Paulmurugan R
    Invest Radiol; 2020 Nov; 55(11):711-721. PubMed ID: 32569010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma.
    Wei S; Fu N; Sun Y; Yang Z; Lei L; Huang P; Yang B
    Ultrasound Med Biol; 2014 Jun; 40(6):1250-9. PubMed ID: 24613557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Lipopeptide-Based αvβ₃ Integrin-Targeted Ultrasound Contrast Agent for Molecular Imaging of Tumor Angiogenesis.
    Yan F; Xu X; Chen Y; Deng Z; Liu H; Xu J; Zhou J; Tan G; Wu J; Zheng H
    Ultrasound Med Biol; 2015 Oct; 41(10):2765-73. PubMed ID: 26166460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55).
    Bzyl J; Palmowski M; Rix A; Arns S; Hyvelin JM; Pochon S; Ehling J; Schrading S; Kiessling F; Lederle W
    Eur Radiol; 2013 Feb; 23(2):468-75. PubMed ID: 22878592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.